Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce pharma]
https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw
Cannabis Stocks Rally Anew as $7 Billion GW Pharma Deal Spurs Interest in Weed and its Medical Benefits [MarketWatch]
https://www.marketwatch.com/story/cannabis-stocks-rally-anew-as-7-billion-gw-pharma-deal-spurs-interest-in-weed-and-its-medical-benefits-11612376529
Medical cannabinoids (CBD) and brain tumours – Interview with Dr. Wai Liu (via Brain Tumour Research)
https://www.braintumourresearch.org/media/our-blog/blog-item/our-blog/2019/04/05/medical-cannabinoids-(cbd)-and-brain-tumours---interview-with-dr-wai-liu
Cannabis Executives Reveal The Industry’s 2019 Challenges And A Few Opportunities Too
https://www.forbes.com/sites/julieweed/2019/02/19/cannabis-executives-reveal-the-industrys-2019-challenges-and-a-few-opportunities-too/
